COPENHAGEN (Thomson Financial) - Danish pharmaceutical company Lundbeck AS raised its full year operating profit guidance to "more than 2.6 bln dkr" from "more than 2.5 bln dkr", as it posted a third quarter pretax profit of 1.019 bln dkr, up 56 pct year-on-year and ahead of consensus estimates, according to RB Boersen, of 916 mln dkr.
From: www.sharewatch.com
Lundbeck upgrades FY guidance as Q3 pretax beats consensus
Posted by Ruslan Abuzant at 1:03 AM
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment